Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

BACKGROUND: Biomarkers that can be used to accurately assess the residual risk of disease recurrence in women with hormone receptor–positive breast cancer are clinically valuable. We evaluated the prognostic value of the Breast Cancer Index (BCI), a continuous risk index based on a combination of HO...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res
Autori principali: Sgroi, Dennis C., Chapman, Judy-Anne W., Badovinac-Crnjevic, T., Zarella, Elizabeth, Binns, Shemeica, Zhang, Yi, Schnabel, Catherine A., Erlander, Mark G., Pritchard, Kathleen I., Han, Lei, Shepherd, Lois E., Goss, Paul E., Pollak, Michael
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4700696/
https://ncbi.nlm.nih.gov/pubmed/26728744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0660-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi